News

The double-blinded, randomized, placebo-controlled trial will assess cobiprostone (SPI-8811), safety and efficacy in preventing NSAID-induced gastric and duodenal ulcers, erosions and dyspeptic symptoms in patients with arthritis. Sucampo

Michael Tardugno, president and CEO, said: “The FDA’s request is consistent with the SPA process and does not in any way suggest that approvability of our pivotal study

Ciclopirox nail lacquer is a prescription pharmaceutical product used for the topical treatment of onychomycosis. Taro says the FDA has determined that its ciclopirox nail lacquer is safe

The committee for medicinal products for human use (CHMP)’s opinion for Torisel will now be forwarded to the European Commission for final approval, anticipated in November 2007. Torisel

Frank Zheng, managing director of JPI, said: “Our new product development strategy is expected to provide at least an additional six new products to the company’s existing family

The patent covers a method for improving sexual function by activating serotonin or dopamine neurotransmission, or a combination of both. The compound is initially being developed for the

The transaction adds FV-100, an orally bioavailable bicyclic nucleoside analogue for the treatment of shingles and a series of preclinical compounds for the treatment of human cytomegalovirus disease

UBS Investment Bank, CIBC World Markets and Morgan Stanley acted as joint book-running managers for the offering. The price to the public is $23.15, and proceeds to the

Roche’s $3 billion hostile bid for Ventana is set to expire on November 1. Roche has said approximately 63,541 shares have been tendered pursuant to the offer. That’s